Paliperidone Palmitate 3-month Versus 1-month Formulation In Patients With Schizophrenia: A Randomized, Double-blind, Noninferiority Study

被引：0
|
作者：
Savitz, Adam [1 ]
Xu, Haiyan [1 ]
Gopal, Srihari [1 ]
Nuamah, Isaac [1 ]
Ravenstijn, Paulien [2 ]
Janik, Adam [3 ]
Schotte, Alain [2 ]
Hough, David [1 ]
Fleischhacker, Wolfgang W. [4 ]
机构：
[1] Johnson & Johnson Pharmaceut R&D, Neurosci, Titusville, NJ USA
[2] Johnson & Johnson Pharmaceut R&D, Neurosci, Beerse, Belgium
[3] Janssen Cilag, Neurosci, Warsaw, Poland
[4] Innsbruck Med Univ, Dept Psychiat & Psychotherapy, Innsbruck, Austria
来源：
BIOLOGICAL PSYCHIATRY | 2016年 / 79卷 / 09期
关键词：
Paliperidone; 1; monthly; 3; schizophrenia; relapse; PANSS;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
1034
引用
收藏
页码：354S / 354S
页数：1
相关论文
共 50 条
  • [41] Caregiver Burden in Schizophrenia: Pooled Analysis of the Involvement Evaluation Questionnaire Data for Paliperidone Palmitate 3-month Formulation
    Gopal, Srihari
    Xu, Haiyan
    McQuarrie, Kelly
    Savitz, Adam
    Nuamah, Isaac
    Woodruff, Kimberly
    Mathews, Maju
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 213S - 213S
  • [42] Caregiver Burden In Schizophrenia: Pooled Analysis Of The Involvement Evaluation Questionnaire Data For Paliperidone Palmitate 3-Month Formulation
    Gopal, S.
    Xu, H.
    McQuarrie, K.
    Savitz, A.
    Nuamah, I
    Woodruff, K.
    Mathews, M.
    VALUE IN HEALTH, 2016, 19 (03) : A191 - A191
  • [43] SWITCHING SCENARIOS FOR PALIPERIDONE PALMITATE 3-MONTH FORMULATION IN SCHIZOPHRENIA: A POPULATION PHARMACOKINETIC SIMULATION-BASED EVALUATION
    Gopal, S.
    Vermeulen, A.
    Nandy, P.
    Ravenstijn, P.
    Nuamah, I.
    Vidal, J.
    Berwaerts, J.
    Savitz, A.
    Hough, D.
    Samtani, M.
    Russu, A.
    Reeve-Parker, K.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 161 - 162
  • [44] Switching Scenarios for Paliperidone Palmitate 3-month Formulation in Schizophrenia: A Population Pharmacokinetic Simulation-based Evaluation
    Gopal, Srihari
    Vermeulen, An
    Nandy, Partha
    Ravenstijn, Paulien
    Nuamah, Isaac
    Vidal, Jose Antonio Buron
    Savitz, Adam
    Hough, David
    Samtani, Mahesh N.
    Russu, Alberto
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 72S - 72S
  • [45] Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia
    Garcia-Portilla, Maria Paz
    Llorca, Pierre-Michel
    Maina, Giuseppe
    Bozikas, Vasilis P.
    Devrimci-Ozguven, Halise
    Kim, Sung-Wan
    Bergmans, Paul
    Usankova, Irina
    Pungor, Katalin
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020, 10
  • [46] Population Pharmacokinetic/Pharmacodynamic Modeling of Paliperidone Palmitate 3-Month Formulation in Asian Population
    Russu, Alberto
    Mathews, Maju
    Savitz, Adam
    Gopal, Srihari
    Feng, Yu
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 242 - 242
  • [47] An assessment of injection site reaction and injection site pain of 1-month and 3-month long-acting injectable formulations of paliperidone palmitate
    Sliwa, Jennifer Kern
    Savitz, Adam
    Nuamah, Isaac
    Mathews, Maju
    Gopal, Srihari
    Elefant, Erica
    Najarian, Dean
    Alphs, Larry
    PERSPECTIVES IN PSYCHIATRIC CARE, 2018, 54 (04) : 530 - 538
  • [48] Functionality in patients with newly diagnosed schizophrenia treated with paliperidone palmitate 3-month formulation in real-world clinical practice study (TIME study)
    Garcia-Portilla, M. P.
    Gomez, F.
    Benito, A.
    Lopez, P.
    Garcia, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S470 - S471
  • [49] Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate 3-Month Formulation in Patients With Schizophrenia: A Phase-I, Single-Dose, Randomized, Open-Label Study
    Ravenstijn, Paulien
    Remmerie, Bart
    Savitz, Adam
    Samtani, Mahesh N.
    Nuamah, Isaac
    Chang, Cheng-Tao
    De Meulder, Marc
    Hough, David
    Gopal, Srihari
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (03): : 330 - 339
  • [50] Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study
    Savitz, Adam J.
    Xu, Haiyan
    Gopal, Srihari
    Nuamah, Isaac
    Ravenstijn, Paulien
    Hough, David
    Mathews, Maju
    Feng, Yu
    Yu, Lu
    Takahashi, Masayoshi
    Liu, Dennis
    Wang, Gang
    Yoon, Jin-Sang
    Chen, Jiahn-Jyh
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2193 - 2207
12345